Long-Term Serum Amyloid A Profile in Clinically Stable Pediatric Liver Transplant Recipients


Creative Commons License

Aydemir S., Özden İ., Önal Z., Cantez S., Durmaz Ö.

Turkish Journal of Gastroenterology , cilt.37, sa.11, ss.1-8, 2026 (TRDizin)

Özet

ABSTRACT

ABSTRACT: Background/Aims: Serum amyloid A (SAA) is an acute-phase protein whose sustained elevation is required for AA amyloid fibril forma-tion. Although AA amyloidosis is a rare complication of solid organ transplantation, the long-term SAA profile of clinically stable pedi-atric liver transplant recipients remains unknown. This study aimed to characterize long-term SAA concentrations in this population.Materials  and  Methods:  This  observational  study  included  51  pediatric  liver  transplant  recipients  and  50  children  with  acute  febrile  infections.  Cross-sectional  SAA  measurements  were  obtained  in  clinically  stable  recipients  at  least  6  months  after  transplantation.  Children  with  acute  febrile  infections  served  as  a  high-inflammation  reference  group.  In  addition,  7  recipients  underwent  serial  SAA  measurements before transplantation and at 1 week, 1 month, and 6 months after transplantation.Results: Median SAA concentrations were significantly lower in clinically stable transplant recipients than in children with acute infec-tion (4.2 mg/L [0.7-71.8] vs. 172 mg/L [1.5-961], P < .001). SAA concentrations ≥10 mg/L were observed in 14% of transplant recipients and 96% of children with acute infections. In the longitudinal subgroup, SAA concentrations increased during the early postoperative period and declined toward baseline by 6 months (P = .014).Conclusion: SAA concentrations were generally low in clinically stable pediatric liver transplant recipients during long-term follow-up but were substantially higher in children with acute infections. These findings provide insight into long-term SAA concentrations in this population and address an important gap in the literature.Keywords: Acute-phase reactants, biomarkers, C-reactive protein, inflammation, pediatric liver transplantation, serum amyloid A/Aims: Serum amyloid A (SAA) is an acute-phase protein whose sustained elevation is required for AA amyloid fibril forma-tion. Although AA amyloidosis is a rare complication of solid organ transplantation, the long-term SAA profile of clinically stable pedi-atric liver transplant recipients remains unknown. This study aimed to characterize long-term SAA concentrations in this population.Materials and Methods: This observational study included 51 pediatric liver transplant recipients and 50 children with acute febrile infections. Cross-sectional SAA measurements were obtained in clinically stable recipients at least 6 months after transplantation. Children with acute febrile infections served as a high-inflammation reference group. In addition, 7 recipients underwent serial SAA measurements before transplantation and at 1 week, 1 month, and 6 months after transplantation.Results: Median SAA concentrations were significantly lower in clinically stable transplant recipients than in children with acute infec-tion (4